423 related articles for article (PubMed ID: 12769843)
1. Skp2 regulates Myc protein stability and activity.
Kim SY; Herbst A; Tworkowski KA; Salghetti SE; Tansey WP
Mol Cell; 2003 May; 11(5):1177-88. PubMed ID: 12769843
[TBL] [Abstract][Full Text] [Related]
2. The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription.
von der Lehr N; Johansson S; Wu S; Bahram F; Castell A; Cetinkaya C; Hydbring P; Weidung I; Nakayama K; Nakayama KI; Söderberg O; Kerppola TK; Larsson LG
Mol Cell; 2003 May; 11(5):1189-200. PubMed ID: 12769844
[TBL] [Abstract][Full Text] [Related]
3. The G1 phase E3 ubiquitin ligase TRUSS that gets deregulated in human cancers is a novel substrate of the S-phase E3 ubiquitin ligase Skp2.
Jamal A; Swarnalatha M; Sultana S; Joshi P; Panda SK; Kumar V
Cell Cycle; 2015; 14(16):2688-700. PubMed ID: 26038816
[TBL] [Abstract][Full Text] [Related]
4. Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc.
Salghetti SE; Kim SY; Tansey WP
EMBO J; 1999 Feb; 18(3):717-26. PubMed ID: 9927431
[TBL] [Abstract][Full Text] [Related]
5. Myc-enhanced expression of Cul1 promotes ubiquitin-dependent proteolysis and cell cycle progression.
O'Hagan RC; Ohh M; David G; de Alboran IM; Alt FW; Kaelin WG; DePinho RA
Genes Dev; 2000 Sep; 14(17):2185-91. PubMed ID: 10970882
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus X protein enhances Myc stability by inhibiting SCF(Skp2) ubiquitin E3 ligase-mediated Myc ubiquitination and contributes to oncogenesis.
Lee S; Kim W; Ko C; Ryu WS
Oncogene; 2016 Apr; 35(14):1857-67. PubMed ID: 26165841
[TBL] [Abstract][Full Text] [Related]
7. Proteolytic control of the oncoprotein transcription factor Myc.
Thomas LR; Tansey WP
Adv Cancer Res; 2011; 110():77-106. PubMed ID: 21704229
[TBL] [Abstract][Full Text] [Related]
8. Pin1 regulates the dynamics of c-Myc DNA binding to facilitate target gene regulation and oncogenesis.
Farrell AS; Pelz C; Wang X; Daniel CJ; Wang Z; Su Y; Janghorban M; Zhang X; Morgan C; Impey S; Sears RC
Mol Cell Biol; 2013 Aug; 33(15):2930-49. PubMed ID: 23716601
[TBL] [Abstract][Full Text] [Related]
9. The Smad7-Skp2 complex orchestrates Myc stability, impacting on the cytostatic effect of TGF-β.
Kim TA; Kang JM; Hyun JS; Lee B; Kim SJ; Yang ES; Hong S; Lee HJ; Fujii M; Niederhuber JE; Kim SJ
J Cell Sci; 2014 Jan; 127(Pt 2):411-21. PubMed ID: 24259667
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7.
Yada M; Hatakeyama S; Kamura T; Nishiyama M; Tsunematsu R; Imaki H; Ishida N; Okumura F; Nakayama K; Nakayama KI
EMBO J; 2004 May; 23(10):2116-25. PubMed ID: 15103331
[TBL] [Abstract][Full Text] [Related]
11. CRTC1/MAML2 gain-of-function interactions with MYC create a gene signature predictive of cancers with CREB-MYC involvement.
Amelio AL; Fallahi M; Schaub FX; Zhang M; Lawani MB; Alperstein AS; Southern MR; Young BM; Wu L; Zajac-Kaye M; Kaye FJ; Cleveland JL; Conkright MD
Proc Natl Acad Sci U S A; 2014 Aug; 111(32):E3260-8. PubMed ID: 25071166
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes.
Gartel AL; Shchors K
Exp Cell Res; 2003 Feb; 283(1):17-21. PubMed ID: 12565816
[TBL] [Abstract][Full Text] [Related]
13. N-myc downstream regulated gene 1(NDRG1) promotes the stem-like properties of lung cancer cells through stabilized c-Myc.
Wang Y; Zhou Y; Tao F; Chai S; Xu X; Yang Y; Yang Y; Xu H; Wang K
Cancer Lett; 2017 Aug; 401():53-62. PubMed ID: 28456659
[TBL] [Abstract][Full Text] [Related]
14. Targeted destruction of c-Myc by an engineered ubiquitin ligase suppresses cell transformation and tumor formation.
Hatakeyama S; Watanabe M; Fujii Y; Nakayama KI
Cancer Res; 2005 Sep; 65(17):7874-9. PubMed ID: 16140957
[TBL] [Abstract][Full Text] [Related]
15. A license to kill: transcriptional activation and enhanced turnover of Myc by the SCF(kp2) ubiquitin ligase.
Jin J; Harper JW
Cancer Cell; 2003 Jun; 3(6):517-8. PubMed ID: 12842079
[TBL] [Abstract][Full Text] [Related]
16. SNIP1: Myc's new helper in transcriptional activation.
Larsson LG
Mol Cell; 2006 Dec; 24(6):811-2. PubMed ID: 17189184
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus nuclear antigen 3C interacts with and enhances the stability of the c-Myc oncoprotein.
Bajaj BG; Murakami M; Cai Q; Verma SC; Lan K; Robertson ES
J Virol; 2008 Apr; 82(8):4082-90. PubMed ID: 18256156
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional repression by Myc.
Wanzel M; Herold S; Eilers M
Trends Cell Biol; 2003 Mar; 13(3):146-50. PubMed ID: 12628347
[TBL] [Abstract][Full Text] [Related]
19. Skp2 is necessary for Myc-induced keratinocyte proliferation but dispensable for Myc oncogenic activity in the oral epithelium.
Sistrunk C; Macias E; Nakayama K; Kim Y; Rodriguez-Puebla ML
Am J Pathol; 2011 Jun; 178(6):2470-7. PubMed ID: 21641375
[TBL] [Abstract][Full Text] [Related]
20. ERK-dependent downregulation of Skp2 reduces Myc activity with HGF, leading to inhibition of cell proliferation through a decrease in Id1 expression.
Li X; Bian Y; Takizawa Y; Hashimoto T; Ikoma T; Tanaka J; Kitamura N; Inagaki Y; Komada M; Tanaka T
Mol Cancer Res; 2013 Nov; 11(11):1437-47. PubMed ID: 24177224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
